RecruitingNCT01258231

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Sponsor

Brigham and Women's Hospital

Enrollment

4,000 participants

Start Date

Aug 1, 2000

Study Type

OBSERVATIONAL

Conditions

Heart Failure Atrial Fibrillation Genetic Predisposition to Disease Myocardial Infarction Heart; Dysfunction Postoperative, Cardiac Surgery

Summary

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Eligibility

Min Age: 20 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether a person's genes can predict which patients will experience serious complications (like kidney problems or heart issues) after heart surgery, which could help doctors provide more personalized care. **You may be eligible if...** - You are scheduled to undergo heart surgery - You are willing to provide consent **You may NOT be eligible if...** - You are already enrolled in another drug or device trial that does not allow simultaneous enrollment in this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.